Akèy › Amiloidoz ereditè ki gen rapò ak transthyretin › Oregon › Portland
Etid klinik pou Amiloidoz ereditè ki gen rapò ak transthyretin nan Portland, OR
4 etid pou Amiloidoz ereditè ki gen rapò ak transthyretin ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
- Research Site, Portland
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- Oregon Health & Science University, Portland
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Ap rekriteFaz 2
- Oregon Health & Science University, Portland
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
- Oregon Health and Science University (OHSU), Portland
Etid Amiloidoz ereditè ki gen rapò ak transthyretin nan lòt vil
- New York City, NY5 etid
- Los Angeles, CA5 etid
- Dallas, TX4 etid
- Boston, MA4 etid
- Philadelphia, PA4 etid
- Durham, NC4 etid
- Baltimore, MD4 etid
- San Diego, CA4 etid
- Richmond, VA3 etid
- Washington, DC3 etid
- Kansas City, MO3 etid
- Rochester, MN3 etid
Lòt etid nan Portland
- Kansè Poumon ki pa ti selil46 etid
- Kansè (tout kalite)34 etid
- Kansè nan tete33 etid
- Kansè pwostat33 etid
- Kansè Metastatik29 etid
- Kansè kolorektal28 etid
- Kansè ovè27 etid
- Kansè poumon26 etid
- Leksemi mieloïd egi25 etid
- Kansè Endomèt24 etid
- Karsinòm selil skuamèz tèt ak kou19 etid
- Kansè pankreyas19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.